Acute and chronic infections caused by the opportunistic pathogen Pseudomonas aeruginosa pose a serious threat to human health care worldwide and the increasing resistance to antibiotics entails the requirement of more effective and alternative treatment strategies.
INTRODUCTION
Pseudomonas aeruginosa is an opportunistic bacterial pathogen that causes both livethreatening acute and devastating chronic infections in the human host . In cystic fibrosis (CF) patients the respiratory tract is especially prone to chronic infections caused by the most dominant bacterial pathogen P. aeruginosa and these infections largely determine the fate and prognosis in these patients . Improved antimicrobial treatment strategies strongly increased the life-expectancy of CF patients in the last decades. Nevertheless, even aggressive antimicrobial therapy rarely eradicates established chronic P. aeruginosa infections . Hence, for the management of chronic infectious diseases, there is a strong need for alternative treatment strategies that amend classical antimicrobial therapy . Several clinical studies have now demonstrated that CF patients and patients suffering from diffuse panbronchiolitis (DPB), who are chronically infected with P. aeruginosa, benefit from treatment with the macrolide azithromycin (AZM), although the 14-and 15-C macrolides (erythromycin, azithromycin and clarithromycin) do not inhibit growth of P. aeruginosa at concentration levels below the breakpoint concentration for susceptibility to the macrolides .
The nature of this beneficial effect of AZM is still unclear. Macrolides were shown to have an immunomodulatory activity, which results in a decreased inflammatory response to bacterial stimulations , and there are several studies demonstrating that macrolides inhibit virulence factor production in P. aeruginosa in vitro and in vivo and to interfere with biofilm formation .
Although macrolides are antibacterial agents that target the protein synthesis machinery, at subinhibitory concentrations AZM was demonstrated to both activate and repress the transcription of different subsets of genes in P. aeruginosa . It remains uncertain how these effects on transcriptions are mediated. Recently, it was clearly shown that bacterial stationary phase cell killing and reduced expression of quorum sensing-dependent virulence factors require the interaction of AZM with the ribosome , indicating that there do not seem to be non-ribosomal targets of AZM which could explain the AZM-mediated effects on P. aeruginosa. Furthermore, it was demonstrated that the bacteriotoxic activity of the macrolides is presumably caused by a combination of inhibition of protein elongation, on the one hand, and depletion of the intracellular pools of aminoacyl-tRNAs by drop-off and incomplete peptidyl-tRNA hydrolase (Pth) activity, on the other hand . Pth is an essential enzyme and releases tRNA from the premature translation termination product peptidyl-tRNA by cleaving the ester bond between the peptide and the tRNA, thus allowing the tRNA species to return to the pool of accessible tRNAs available for protein synthesis .
In this study we aimed at analyzing to what extent a decreased intracellular tRNA pool also contributes to the observed AZM-mediated phenotype in respect to virulence factor production, motility and stationary phase cell killing in P. aeruginosa. Our results show that increasing the intracellular pools of tRNAs by over-expressing the peptidyl-tRNA hydrolase encoded by PA4672 clearly counteracted AZM induced stationary phase killing, reduced expression of rhamnolipids, pyocyanin, and swarming motility and increased cytotoxicity in P. aeruginosa cells. Furthermore, the AZM effect on rhamnolipid production could be explicitly diminished by the exchange of a rarely to a frequently used codon for arginine at the second position of rhlR. Our results suggest that AZM impacts on protein expression on a global scale and selectively impairs the expression of those proteins with an increased frequency of rare codons. 
MATERIALS AND METHODS:
Strains and plasmids. Bacterial strains and plasmids used in this study are summarized in Table 1 . Escherichia coli DH5α and Pseudomonas aeruginosa PA14 (PA14) strains were routinely grown in Lysogeny Broth (LB) at 37°C with or without the addition of azithromycin (AZM; Pfizer, Germany) at given concentrations. For solidification, agar was added to a final concentration of 1.5 % (w/v). 100 µg/ml ampicillin and 400 µg/ml carbenicillin were added to inhibit E. coli and PA14 growth, respectively.
DNA manipulations were performed according to standard protocols or following the manufacturer's instructions. Kits for the isolation of chromosomal DNA, isolation of plasmids and purification of polymerase chain reaction (PCR) products were purchased from Quiagen GmbH (Hilden, Germany). Enzymes were purchased from Roche Diagnostics Deutschland GmbH (Mannheim, Germany) and Fermentas (St Leon-Rot, Germany).
For over-expression of PA4672 (pth) the plasmid pHERD-pth was constructed. The pth gene was PCR-amplified using PA14 genomic DNA as template. The primers used are listed in Table 1 . The resulting PCR product including an artificial ribosomal binding site was ligated in-frame into the NcoI/PstI site of pHERD20T . The resulting vector was introduced into PA14 by electroporation and pHERD20T empty plasmid was introduced into PA14 serving as wild-type control (wt control). The pth over-expression was induced with 0.2 % (w/v) arabinose at an OD 600nm of 0.3-0.5.
To generate the plasmids pUCP20::rhlR and pUCP20::rhlR-R2R (encoding the rhlR gene with the codon change from AGG to CGC at the second position), the rhlR gene was amplified from P. aeruginosa PA14 chromosomal DNA using the forward primers "rhlR- were separately used as templates for a second PCR using the primers "pET21A-pUCP20-fw"
and "pET21A-pUCP20-rv". The PCR products were digested with EcoRI/XbaI and finally cloned into similar digested pUCP20, resulting in the plasmids pUCP20::rhlR-R2R and pUCP20::rhlR, which were verified by sequence analysis (data not shown).
Total tRNA isolation and hybridization with a Cy3-tagging oligonucleotide. Total tRNA was isolated by mixing 10 ml cell culture with 10 ml cold 10% (w/v) trichloroacetic acid.
After centrifugation (3500 x g for 15 min at 4°C) the cell pellet was resuspended in ice cold 0.5 ml of lysis buffer [0.3M sodium acetate (pH 4.5) and 10 mM Na 2 EDTA] and transfered to a fresh 1.5-ml Eppendorf tubes (on ice). The lysate was mixed with 0.5 ml acetate-saturated DMSO and 1 U T4 DNA ligase for 15 h at 16°C. The ligation reaction was separated using a 2% agarose gel electrophoresis and fluorescence intensity was detected by a FLA-9000 FUJIFILM fluorescence scanner followed by a densiometric analysis using the software ImageJ vs. 1.43u . As sample handling control, the total tRNA amount was measured by poststaining of the agarose gel with GelStar™ Nucleic Acid Gel Stain (LONZA) and a standard UV transilluminator (312 nm).
Stationary phase killing assay. The killing assay was performed essentially as described earlier . In brief, overnight cultures of plasmid harboring PA14 strains grown in LB supplemented with carbenicillin were diluted to an OD 600nm of 0.05 with antibiotic-free medium and incubated at 37°C. After reaching stationary phase (OD 600nm ~ 3.0), AZM (2, 5 or 10 µg/ml) was added to 2-ml aliquots of the cultures and the incubation was continued for 20 h at 37°C. The viable counts were determined by plating serial dilution aliquots onto LB agar plates. The relative survival of each strain was normalized to that of the non-treated wild-type control.
Quantification of rhamnolipid production. Overnight cultures were freshly diluted to an OD 600nm of 0.05 and incubated in LB supplemented with or without AZM at 37°C for 48 h.
The colorimetric analysis of the orcinol reaction was adopted from . 300 µl of culture supernatant were extracted twice with diethylether and the pooled ether fractions were evaporated to dryness. The remainders were dissolved in distilled water and incubated with 100 µl 1.6 % (w/v) orcinol and 800 µl 60 % sulfuric acid at 80°C for 30 min. The adsorption at 421 nm was determined. In parallel, rhamnose at defined concentrations was also assayed as described above and used as a standard for determining the rhamnose in the culture samples. Rhamnolipid concentrations were then calculated based on the assumption that 1 µg of rhamnose corresponds to 2.5 µg of rhamnolipid .
Assay for pyocyanin production. Pyocyanin production was determined as described previously . Briefly, a 5-ml aliquot of 24 h-old bacterial cultures grown in the absence or presence of AZM were extracted with chloroform and then re-extracted into 0.2 N HCl to give a pink solution. The absorbance was measured at 520 nm, and the pyocyanin produced per milliliter of culture supernatant was calculated as described elsewhere .
Cytotoxicity assay. A549-Gluc cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 2 mM L-glutamine, non-essential amino acids, 100U of penicillin per ml, 100 µg of streptomycin per ml, and 10 % fetal calf serum (DMEM complete). Cultures were grown at 37°C with 5% CO 2 . A549-Gluc cells were generated from A549 by lentiviral gene transfer as previously described . Antibiotic selection was done by growing cultures in the presence of 10µg/ml blasticidin.
Cytotoxicity of AZM-treated and non-treated P. aeruginosa strains were assessed by infecting A549-Gluc cells, which secrete Gaussia luciferase as a measure of cell integrity. A549-Gluc cells were seeded in 96 well plates at a density of 2. peptidyl-tRNA pool, we would expect that in the pth overexpressing strain PA14-pth the relative abundance of uncharged versus amino-acetylated tRNAs should be increased. Indeed, as depicted in Fig. 1 , over-expression of pth leads to an increased ligation efficiency of the tRNAs to the Cy3-tagging oligonucleotides of about two-fold. This is expected to be due to the absence of the peptidyl moiety which, if present presumably leads to a hindrance of the ligation process. Vice versa, if the total tRNA pool in the pth over-expressing strain was pretreated with periodate, which oxidizes uncharged tRNAs and thus hinders the ligation process, the efficiency of ligation was reduced. By a permanent delivery of Pth recycled tRNAs, the intracellular pool of tRNAs is constantly filled up with uncharged tRNA, which presumably also increases the overall amount of amino-acetylated tRNAs as more freely accessible tRNAs are present in the cell.
AZM stationary phase killing is decreased in pth over-expressing P. aeruginosa cells. In previous studies it was shown that AZM mediates killing of stationary-phase cells of P. aeruginosa . Hence, we analyzed whether pth over-expression and the resulting increase of free available tRNAs counteracts the AZM-mediated killing effect. P. aeruginosa PA14 wildtype control and PA14 over-expressing pth (PA14-pth) were grown to stationary phase and subjected to AZM concentrations of 2 µg/ml, 5 µg/ml or 10 µg/ml (Fig. 2) . Whereas supplementation with 10 µg/ml AZM had a strong bactericidal effect on both PA14 and PA14-pth cells, the AZM-mediated killing on cells that over-expressed the Pth enzyme was significantly compensated when treated with 2 µg/ml and 5 µg/ml AZM, respectively. This shown to inhibit the production of mainly rhl-quorum sensing-dependent production of virulence factors, including pyocyanin and rhamnolipids, and inhibit swarming motility in P. aeruginosa . We cultured PA14 wild type and PA14-pth in LB with and without adding 2 µg/ml, 5 µg/ml or 10 µg/ml AZM. Whereas higher concentrations of AZM (5 µg/ml or 10 µg/ml) led to a reduced growth rate in the late exponential / early stationary phase in both strains, lower concentrations of AZM (2 µg/ml) only slightly impacted bacterial growth (Fig.   3 ). Interestingly, under low AZM concentrations rhamnolipid and pyocyanin production were significantly reduced (Fig. 4) . When over-expressing pth in AZM-treated cells (2 µg/ml), rhamnolipid production could be restored to wild-type levels, whereas pyocyanin production was only partially restored. Importantly, over-expression of pth in none-treated P. aeruginosa cells already revealed an enhanced production of both rhamnolipid and pyocyanin, indicating that the availability of tRNAs for amino-acetylation is critical for the expression of rhl-
To further analyze whether changes in the tRNA pools also have an influence on the swarming motility, we cultured PA14 wild type and PA14-pth on BM2 agar plates containing different concentrations of AZM. Interestingly, over-expressing pth led to de-repression of swarming activity in cells treated with 2 µg/ml or 5 µg/ml AZM as compared to the wild-type control (Fig. 5) . This suggests that the Pth-dependent recycling of peptidyl-tRNAs results in an enlarged pool of free tRNAs which counteracts the AZM-mediated inhibitory effect of P. aeruginosa swarming motility. Codon usage plays a role in rhlR translation efficiency of AZM treated cells. Obviously, upon treatment with subinhibitory AZM concentrations the translation of only some targets proceeds less efficiently, whereas others seem to be unaffected and growth is hardly inhibited in P. aeruginosa upon the addition of 2 µg/ml AZM. Since we found that the accumulation of peptidyl-tRNAs and therefore, the decreased availability of tRNAs is critical for the effect of AZM on the expression of rhl-mediated phenotypes, we wondered whether the deprivation of distinct tRNA isoacceptors that bind to different codons for the same amino acid might affect the translation efficiency of the RhlR encoding mRNA. We found that the second codon of the rhlR gene was AGG which is read by an arginine tRNA isoacceptor that is very rarely used during P. aeruginosa protein synthesis (2.1 per thousand; www.kazusa.or.jp). In order to determine whether codon usage plays a role in translation efficiency in AZM treated cells, we As depicted in Fig. 7 the exchange of the rarely to the frequently used codon significantly reduced the AZM-mediated inhibitory effect on the production of rhamnolipids and pyocyanin. Of note, albeit the AZM-mediated repression of the swarming motility was partially restored in the PA14 strain complemented with rhlR in trans, the exchange of the rarely used second codon in rhlR to the frequently used GCG did not make a difference even when higher AZM concentrations were used (Fig. 8) . Thus, although many of the AZMmediated effects on P. aeruginosa are at least partially due to a reduced expression of RhlR, these results indicate that other factors besides the AZM-mediated effect on rhamnolipid production play a role in the AZM-mediated repression of swarming motility and there seem to be other yet to be identified targets of AZM.
Conclusion
Over-expression of Pth in PA14 wild-type cells revealed a diametrically opposed phenotype to that seen in PA14 exposed to subinhibitory AZM concentrations, and the AZM-mediated effects on the RhlR-dependent phenotypes could be diminished by increasing the availability of uncharged tRNAs via over-expression of Pth. These results indicate that an AZM-mediated increased peptidyl-tRNA drop-off can be counteracted by an enhanced recycling of tRNAs.
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